ReviewBioMed research international2013
Materials and manufacturing technologies available for production of a pediatric bioabsorbable stent.
Review in BioMed research international, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed.
- An Overview of Advanced Materials and Manufacturing Strategies for 3D-Printed Bioengineered Vascular Stents: Toward Next-Generation Drug Delivery Applications.Pharmaceutics · 2026Review
- A novel iron bioresorbable scaffold: a potential strategy for pulmonary artery stenosis.Regenerative biomaterials · 2025Article
- Synchrotron microtomography reveals insights into the degradation kinetics of bio-degradable coronary magnesium scaffolds.Bioactive materials · 2024Article
- Accelerated degradation testing impacts the degradation processes in 3D printed amorphous PLLA.Frontiers in bioengineering and biotechnology · 2024Article
- Supracerebellar infratentorial resection of a torcular lesion causing fulminant intracranial hypertension: illustrative case.Journal of neurosurgery. Case lessons · 2023Article
- Advances in Fabrication Technologies for the Development of Next-Generation Cardiovascular Stents.Journal of functional biomaterials · 2023Review
- Bioabsorbable Polymeric Stent for the Treatment of Coarctation of the Aorta (CoA) in Children: A Methodology to Evaluate the Design and Mechanical Properties of PLA Polymer.Materials (Basel, Switzerland) · 2023Article
- Article
- Transcatheter Device Therapy and the Integration of Advanced Imaging in Congenital Heart Disease.Children (Basel, Switzerland) · 2022Review
- Article
- Article
- Raman Spectroscopy as a Novel Method for the Characterization of Polydioxanone Medical Stents Biodegradation.Materials (Basel, Switzerland) · 2021Article
- Development of a polycaprolactone/poly(Bioactive materials · 2021Article
- Bioresorbable Stent to Manage Congenital Heart Defects in Children.Materialia · 2021Article
- Modelling Stretch Blow Moulding of Poly (l-lactic acid) for the Manufacture of Bioresorbable Vascular Scaffold.Polymers · 2021Article
- Pulmonary artery and lung parenchymal growth following early versus delayed stent interventions in a swine pulmonary artery stenosis model.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2020Article
- The Functional Properties of Mg-Zn-X Biodegradable Magnesium Alloys.Materials (Basel, Switzerland) · 2020Article
- Fabrication and Characterization of Bioresorbable Drug-coated Porous Scaffolds for Vascular Tissue Engineering.Materials (Basel, Switzerland) · 2019Article
- Article
- Pharmacokinetic Study of Sirolimus-Eluting BioResorbable Vascular Scaffold System for Treatment ofCardiology research · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Transcatheter treatment of children with congenital heart disease such as coarctation of the aorta and pulmonary artery stenosis currently involves the use of metal stents. While these provide good short term results, there are long term complications with their use. Children outgrow metal stents, obligating them to future transcatheter dilations and eventual surgical removal. A bioabsorbable stent, or a stent that goes away with time, would solve this problem. Bioabsorbable stents are being developed for use in coronary arteries, however these are too small for use in pediatric congenital heart disease. A bioabsorbable stent for use in pediatric congenital heart disease needs to be low profile, expandable to a diameter 8 mm, provide sufficient radial strength, and absorb quickly enough to allow vessel growth. Development of absorbable coronary stents has led to a great understanding of the available production techniques and materials such as bioabsorbable polymers and biocorrodable metals. Children with congenital heart disease will hopefully soon benefit from the current generation of bioabsorbable and biocorrodable materials and devices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.